Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M441Revenue $M70.6Net Margin (%)0.6Altman Z-Score-2.5
Enterprise Value $M432EPS $-0.0Operating Margin %-10.0Piotroski F-Score6
P/E(ttm)--Beneish M-Score5.2Pre-tax Margin (%)0.6Higher ROA y-yY
Price/Book75.110-y EBITDA Growth Rate %--Quick Ratio3.6Cash flow > EarningsN
Price/Sales6.35-y EBITDA Growth Rate %--Current Ratio3.6Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)0.2Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)1.9Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M143ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with ARRY

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ARRYKen Fisher 2015-09-30 Buy $4.56 - $7.11
($5.94)
$ 3.08-48%New holding135,695
ARRYFirst Eagle Investment 2011-12-31 Sold Out -0.0024%$1.77 - $2.83
($2.27)
$ 3.0836%Sold Out0
ARRYGeorge Soros 2011-12-31 Sold Out -0.0008%$1.77 - $2.83
($2.28)
$ 3.0835%Sold Out0
ARRYGeorge Soros 2011-09-30 Buy $1.99 - $2.62
($2.24)
$ 3.0838%New holding22,400
ARRYFirst Eagle Investment 2011-06-30 Add$2.06 - $3.21
($2.7)
$ 3.0814%Add 150.00%250,000
ARRYGeorge Soros 2011-06-30 Sold Out $2.06 - $3.21
($2.7)
$ 3.0814%Sold Out0
ARRYFirst Eagle Investment 2011-03-31 Buy $2.7 - $3.29
($3)
$ 3.083%New holding100,000
ARRYGeorge Soros 2011-03-31 Buy $2.7 - $3.29
($3)
$ 3.083%New holding14,400
ARRYFirst Eagle Investment 2010-09-30 Sold Out -0.01%$2.67 - $3.44
($3.02)
$ 3.082%Sold Out0
ARRYFirst Eagle Investment 2010-06-30 Reduce-0.01%$2.66 - $4.02
($3.41)
$ 3.08-10%Reduce -54.96%450,000
ARRYFirst Eagle Investment 2009-12-31 Add0.01%$1.72 - $2.81
($2.2)
$ 3.0840%Add 62.96%999,132
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ARRY is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ARRY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Redmile Group, LLC10% Owner 2016-01-20Buy300,000$3.19-3.45view
Redmile Group, LLC10% Owner 2016-01-12Buy75,000$3.6-14.44view
Redmile Group, LLC10% Owner 2016-01-11Buy925,000$3.67-16.08view
Redmile Group, LLC10% Owner 2015-10-01Buy782,592$4.58-32.75view
Redmile Group, LLC10% Owner 2015-10-01Buy600,140$4.58-32.75view
Redmile Group, LLC10% Owner 2015-08-26Buy49,900$5.48-43.8view
Redmile Group, LLC10% Owner 2015-08-25Buy790,000$5.38-42.75view
Redmile Group, LLC10% Owner 2015-08-12Buy532,500$5.88-47.62view
Redmile Group, LLC10% Owner 2015-08-10Buy1,048,993$5.8-46.9view
BAUM CHARLES MDirector 2015-05-08Sell25,000$7.38-58.27view

Quarterly/Annual Reports about ARRY:

News about ARRY:

Articles On GuruFocus.com
Screen: Stocks With Estimated Revenue Up 5% - January Jan 18 2016 
Insider Buys Round-up: Tenet Healthcare and Sprint Corp Aug 14 2015 
Novartis Gets FTC Nod To Buyout Glaxo Smithkline’s Cancer Drugs Feb 25 2015 
Can These Three BioTech Companies Make It Big? Feb 20 2015 
Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,310 Shares Mar 16 2011 
Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,403 Shares Feb 11 2011 
Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,272 Shares Jan 13 2011 
Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,256 Shares Dec 10 2010 
Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,220 Shares Nov 12 2010 
Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,225 Shares Oct 13 2010 

More From Other Websites
ARRAY BIOPHARMA INC Files SEC form 10-Q, Quarterly Report May 04 2016
Edited Transcript of ARRY earnings conference call or presentation 4-May-15 1:00pm GMT May 04 2016
Edited Transcript of ARRY earnings conference call or presentation 3-May-16 1:00pm GMT May 03 2016
Array Biopharma Inc Earnings Call scheduled for 9:00 am ET today May 03 2016
ARRAY BIOPHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... May 03 2016
Array BioPharma reports 3Q loss May 03 2016
Array BioPharma reports 3Q loss May 03 2016
Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2016 May 03 2016
8:07 am Array Biopharma misses by $0.05, beats on revs May 03 2016
Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2016 May 03 2016
Q3 2016 Array Biopharma Inc Earnings Release - Before Market Open May 03 2016
Array BioPharma To Report Financial Results For The Third Quarter Of Fiscal 2016 On May 3, 2016 Apr 26 2016
Array BioPharma To Report Financial Results For The Third Quarter Of Fiscal 2016 On May 3, 2016 Apr 26 2016
Why Patents are the Lifeblood of Biotech Companies Apr 25 2016
Array Bio ends late-stage study of ovarian cancer drug Apr 01 2016
Array Bio stops study testing drug for ovarian cancer Apr 01 2016
Array BioPharma Announces Decision To Discontinue MILO Study In Ovarian Cancer Apr 01 2016
ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Apr 01 2016
Array BioPharma Announces Decision To Discontinue MILO Study In Ovarian Cancer Apr 01 2016
Array BioPharma And Asahi Kasei Pharma Corporation Announce Development And Commercialization... Mar 31 2016
ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Mar 31 2016
Array BioPharma And Asahi Kasei Pharma Corporation Announce Development And Commercialization... Mar 31 2016
Five Cheap Healthcare Stocks With Hedge Fund Support Mar 24 2016
Array BioPharma, Inc. breached its 50 day moving average in a Bullish Manner : ARRY-US : March 23,... Mar 23 2016
Array BioPharma, Inc. breached its 50 day moving average in a Bearish Manner : ARRY-US : March 9,... Mar 09 2016
Array Biopharma draws upside position Mar 08 2016
Array BioPharma To Present At The Cowen And Company Annual Healthcare Conference Mar 01 2016
Array BioPharma reports 2Q loss Feb 02 2016
Dana-Farber Cancer Institute's Belfer Center announces Immuno-Oncology research collaboration with... Feb 01 2016
Array BioPharma To Report Financial Results For The Second Quarter Of Fiscal 2016 On February 2,... Jan 26 2016
Array BioPharma To Present At The Annual J.P. Morgan Healthcare Conference Jan 06 2016
Array Announces Closing Of Pierre Fabre Transaction Dec 21 2015
Array BioPharma Announces Phase 3 Binimetinib Trial Meets Primary Endpoint For NRAS-Mutant Melanoma Dec 16 2015
Array BioPharma And Pierre Fabre Announce Development And Commercialization Collaboration For Two... Nov 16 2015
Array BioPharma reports 1Q loss Nov 04 2015
Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2016 Nov 04 2015
Array BioPharma To Report Financial Results For The First Quarter Of Fiscal 2016 On November 4, 2015 Oct 26 2015
Clinical Data Presented On Binimetinib And Encorafenib In Melanoma Sep 28 2015
Array BioPharma To Hold Conference Call To Discuss Clinical Data Presentations In Melanoma And... Sep 25 2015
Array BioPharma Announces Clinical Data Presentations At The 2015 European Cancer Congress Sep 11 2015
Array BioPharma To Present At The Morgan Stanley Global Healthcare Conference Sep 10 2015
Array BioPharma Names Patricia Henahan As Chief Financial Officer Sep 08 2015
Array BioPharma To Present At The Wells Fargo Securities Healthcare Conference Sep 02 2015
Array BioPharma reports 4Q loss Aug 03 2015
Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 Aug 03 2015
Array BioPharma To Report Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 On... Jul 27 2015
Array BioPharma beats Street 3Q forecasts May 04 2015
Array BioPharma reports 2Q loss Feb 03 2015
Array shares jump after drugmaker details Novartis deal Jan 23 2015
Array BioPharma meets 1Q profit forecasts Nov 04 2014

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)